Comet Software acquired MeSoigner, a French healthcare software company specializing in digital solutions for pharmacies, on June 24, 2024. The financial terms of the deal were not disclosed. Comet Software aims to strengthen its market presence and accelerate growth within the pharmacy software segment through this acquisition.
Deal structure and financing
The acquisition of MeSoigner was part of a larger strategic plan by Comet Software to consolidate in the business application software sector following a recent equity raise of €60 million from Otium. The deal specifics, including the exact financial details, are undisclosed. There is no information available on any debt component or lead banks involved in this transaction. No seller retained stake was mentioned, and lock-up terms for MeSoigner's founders were not provided.
Strategic context
Comet Software seeks to enhance its market position by integrating MeSoigner’s specialized software solutions into its portfolio, which complements the company’s existing offerings across various industries. This acquisition is in line with Comet Software’s vision of becoming a leading European player in business application software. The rationale for MeSoigner to divest could be attributed to seeking larger-scale operational support and financial backing from Comet Software while maintaining strategic independence.
Regulatory path
The acquisition of MeSoigner did not require any regulatory approvals, as it falls under the threshold requiring merger control filings in Europe. Given the localized nature of both companies’ operations within France, there were no specific antitrust concerns raised by EU or other national competition authorities. The deal was executed swiftly with minimal regulatory hurdles due to its non-complex structure and limited market impact.